GLOBAL MEDICAL SOLUTIONS SOUTHERN AUSTRALIA PTY LIMITED

Fish oil supplementation reduced the Ki-67 index by 15% in prostate cancer patients on active surveillance, suggesting potential benefits. However, dietary changes complicate attributing results solely to omega-3 and omega-6 fatty acids. Further trials are needed for conclusive evidence.

FDA approves ¹⁸F flurpiridaz PET radiotracer for evaluating suspected MI and ischemia in CAD patients, based on trials showing superiority over SPECT.

The global nuclear medicine market was valued at US$ 5.2 Bn in 2022 and is projected to reach US$ 11.4 Bn by 2031, driven by the increasing prevalence of chronic diseases and the growing availability of radiopharmaceuticals. Nuclear medicine, using radioactive materials for diagnosis and treatment, offers early detection and personalized treatment plans, crucial for conditions like cancer and heart disease. Technological advancements and rising investments in healthcare infrastructure are further fueling market growth.